Glenmark Pharmaceuticals Ltd.: Share Price, Stock Analysis, Annual Report | Value Research Get Glenmark Pharmaceuticals Ltd.'s stock analysis, price valuation, corporate actions, and financials from India's independent mutual fund research house.
quick-summary-circle
company-logo

Click to see a quick summary and important updates about this stock!Dismiss

Glenmark Pharmaceuticals Ltd.

BSE: 532296, NSE: GLENMARK

  • Market Capitalisation market-capitalisation-info ₹12,010 Cr
  • 12 Month Earnings monthly-earning ₹881 Cr
  • Price to Earnings price-to-earning 13.67

₹425.70

As on 24-Mar-2023 IST

up-down-arrow ₹-11.05 • -2.53%

  • Prev Close info

    ₹436.75

  • Day's Openinfo

    ₹433.05

  • Today's Highinfo

    ₹444.95

  • Today's Lowinfo

    ₹423.95

  • Today's Volumeinfo

    10,94,792

Stock Performance
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Glenmark Pharmaceuticals
0.37 -5.02 -0.80 -6.18 31.29 -4.48 -1.31
S&P BSE Healthcare
-6.40 -1.75 -7.34 -11.05 25.12 10.47 10.49
S&P BSE Mid Cap
-6.64 -2.42 -3.25 -0.67 34.51 8.53 14.54
As on 24-Mar-2023
2022
2021
2020
2019
2018
2017
2016
Glenmark Pharmaceuticals
-19.75 5.16 42.75 -49.80 16.26 -33.06 -3.82
S&P BSE Mid Cap
1.38 39.18 19.87 -3.05 -13.31 48.13 7.97
S&P BSE Healthcare
-12.10 20.87 61.45 -3.55 -5.89 0.49 -12.88

Valuation
Stock
Peer Median

Growth & Efficiency
Stock
Peer Median

Solvency

Is there a threat to this company's solvency in the future?

Financial Manipulation

Can creative accounting be detected through the financial numbers?

View Details arrow

Peer Comparison

search
search
search
search
    Comparison Details arrow

    Valuation Chart of Glenmark Pharmaceuticals Ltd.

        Financials

        View Details arrow

        Shareholding Pattern

        View Details arrow

        News & Analysis of Glenmark Pharmaceuticals Ltd.

        ipo-update-glenmark-life-sciences

        IPO update: Glenmark Life Sciences

        By Danish Khanna

        big-shifts

        Big shifts

        By Research Desk

        steely-discipline

        Steely discipline

        picking-cold-stocks-and-converting-them-to-cool-ones

        Picking cold stocks and converting them to cool ones

        small-is-beautiful-in-pharma

        Small is beautiful in pharma

        By Mohammed Ekramul Haque

        the-quest-for-value

        The quest for value

        By Mohammed Ekramul Haque

        All News arrow

        Incorporated

        1977

        Chairman

        Glenn Saldanha

        Managing Director

        Glenn Saldanha

        Group

        Glenmark

        Headquarters

        Mumbai, Maharashtra

        Website

        www.glenmarkpharma.com
        More Details arrow
        Edit peer-selector-edit

        Key Facts

        • Market cap market-cap-information ₹12,010.49 Cr
        • Revenue (TTM)revenue-information ₹12,635.54 Cr
        • Earnings (TTM) earning-information ₹881.14 Cr
        • Cash date-information ₹1,240.04 Cr
        • Total Debt info ₹3,670.35 Cr
        • Promoters' ownership promoters_ownership 46.65%
        • Liquidity liquidity High
        • 52 Week range week-range ₹348.50 - 487.55
        • Face value face-value ₹1.00
        • Shares outstanding share-outstanding 28,21,68,156
        • 10 Years Aggregate:

          CFO: ₹9,590.11 Cr

          EBITDA: ₹16,098.16 Cr

          Net Profit: ₹7,703.74 Cr

        About The Company

        • Business Manufacture of allopathic pharmaceutical preparations
        • Incorporated 1977
        • Chairman Glenn Saldanha
        • Managing Director Glenn Saldanha
        • Group Glenmark
        • Listing key-listing BSE: 532296, NSE: GLENMARK
        • Country India
        • Headquarters headquarters Mumbai, Maharashtra
        • Website website www.glenmarkpharma.com
        Add Portfolio by-stock Add to watchlist watchlist-stock-modal Share Download Stock Report
        Portfolio stock-portfolio Watchlist watchlist-stock-modal share-fund-icon Download Stock Report
        Portfolio stock-investment Watchlist add-watchlist-icon share-fund-plan-icon